Key result
Current research yields no optimal circulating biomarker for clinical risk stratification in BAV aortopathy.
Why the study?
Aortopathy management relies on dimensional parameters to prevent acute aortic events, but most acute aortic dissections occur below surgical thresholds.
Answers are grounded in this paper and cite their sources.
Current reliance on aortic diameter to predict acute aortic events in aortopathy may be insufficient, as many dissections occur below prophylactic surgery thresholds.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Corte et al. (2022) conducted an editorial in Bicuspid aortic valve (BAV) aortopathy. Circulating biomarkers was evaluated. Current research on circulating biomarkers for bicuspid aortic valve aortopathy has not yet identified an optimal candidate for clinical risk stratification, requiring more rigorous study designs.
Synapse has enriched 10 related papers. Consider them for comparative context: